Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
This report aims to provide a comprehensive study of the global market for Psychiatric API.
Report Highlights:
(1) Global Psychiatric API market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Psychiatric API market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Psychiatric API market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Psychiatric API segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Psychiatric API segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Psychiatric API, capacity, production and trends.
(7) Psychiatric API industry supply chain, upstream, midstream and downstream analysis.
According to Latest Research, the global market for Psychiatric API should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Psychiatric API market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Psychiatric API market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Venlafaxine segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Major Depressive Disorder has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Psychiatric API include Pfizer, Eli Lilly, Salutas Pharma, Bora Pharmaceutical, Dr.Reddy's Laboratories, Germany Pharmaceutical, Hengrui Pharmaceuticals, Herui Pharmaceutical and Ren An Pharmaceutical, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
By Product Type, the market is primarily segmented into:
Venlafaxine
Duloxetine
Olanzapine
Paroxetine
Others
By Applications, the market is segmented into:
Major Depressive Disorder
Generalized Anxiety Disorder
Fibromyalgia
Schizophrenia
Others
Key Players Driving the Market:
Pfizer
Eli Lilly
Salutas Pharma
Bora Pharmaceutical
Dr.Reddy's Laboratories
Germany Pharmaceutical
Hengrui Pharmaceuticals
Herui Pharmaceutical
Ren An Pharmaceutical
Yaopharma
Kanghong Pharmaceutical
Brilliant Pharmaceutical
Dongting Pharmaceutical
Sichuan Chuanda West China Pharmaceutical
Yangtze River Pharmaceutical
Huahai Pharmaceutical
1 Market Overview
1.1 Psychiatric API Definition
1.2 Global Psychiatric API Market Size and Forecast
1.2.1 By Revenue, Global Psychiatric API Market Size, 2018-2029
1.2.2 By Sales Volume, Global Psychiatric API Market Size, 2018-2029
1.2.3 Global Psychiatric API Price Trend, 2018-2029
1.3 China Psychiatric API Market Size and Forecast
1.3.1 By Revenue, China Psychiatric API Market Size, 2018-2029
1.3.2 By Sales Volume, China Psychiatric API Market Size, 2018-2029
1.3.3 China Psychiatric API Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Psychiatric API Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Psychiatric API Share in Global Market, 2018-2029
1.4.3 Psychiatric API Market Size: China VS Global, 2018-2029
1.5 Psychiatric API Market Dynamics
1.5.1 Psychiatric API Market Drivers
1.5.2 Psychiatric API Market Restraints
1.5.3 Psychiatric API Industry Trends
1.5.4 Psychiatric API Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Psychiatric API Revenue by Company, 2018-2023
2.2 Global Psychiatric API Sales Volume by Company, 2018-2023
2.3 Global Psychiatric API Price by Company, 2018-2023
2.4 Global Psychiatric API Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Psychiatric API Concentration Ratio
2.6 Global Psychiatric API Mergers & Acquisitions, Expansion Plans
2.7 Global Psychiatric API Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Psychiatric API Revenue by Company, 2018-2023
3.2 China Psychiatric API Sales Volume by Company, 2018-2023
3.3 China Psychiatric API Psychiatric API Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Psychiatric API Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Psychiatric API Domestic VS Export
3.6 China Market, Psychiatric API Import & Export
3.6.1 China Market, Psychiatric API Import & Export, 2018-2029
3.6.2 China Psychiatric API Import & Export Trends
3.6.3 Main Sources of China Psychiatric API Import
3.6.4 Export Destination of China Psychiatric API
4 Psychiatric API Production by Region
4.1 Global Psychiatric API Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Psychiatric API Manufacturers
4.3 Global Major Manufacturers, Psychiatric API Capacity Expansion and Future Plans
4.4 Global Psychiatric API Capacity by Region
4.5 Global Psychiatric API Production by Region
4.5.1 Global Psychiatric API Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Psychiatric API Production by Region, 2018-2023
4.5.3 Global Psychiatric API Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Psychiatric API Industry Chain
5.2 Psychiatric API Upstream Analysis
5.2.1 Psychiatric API Core Raw Materials
5.2.2 Main Manufacturers of Psychiatric API Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Psychiatric API Production Mode
5.6 Psychiatric API Procurement Model
5.7 Psychiatric API Industry Sales Model and Sales Channels
5.7.1 Psychiatric API Sales Model
5.7.2 Psychiatric API Typical Distributors
6 Sights by Type
6.1 Psychiatric API Classification
6.1.1 Venlafaxine
6.1.2 Duloxetine
6.1.3 Olanzapine
6.1.4 Paroxetine
6.1.5 Others
6.2 By Type, Global Psychiatric API Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Psychiatric API Revenue, 2018-2029
6.4 By Type, Global Psychiatric API Sales Volume, 2018-2029
6.5 By Type, Global Psychiatric API Price, 2018-2029
7 Sights by Application
7.1 Psychiatric API Segment by Application
7.1.1 Major Depressive Disorder
7.1.2 Generalized Anxiety Disorder
7.1.3 Fibromyalgia
7.1.4 Schizophrenia
7.1.5 Others
7.2 By Application, Global Psychiatric API Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Psychiatric API Revenue, 2018-2029
7.4 By Application, Global Psychiatric API Sales Volume, 2018-2029
7.5 By Application, Global Psychiatric API Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Psychiatric API Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Psychiatric API Revenue, 2018-2029
8.3 By Region, Global Psychiatric API Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Psychiatric API Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Psychiatric API Market Size Market Share
8.5 Europe
8.5.1 Europe Psychiatric API Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Psychiatric API Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Psychiatric API Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Psychiatric API Market Size Market Share
8.7 South America
8.7.1 South America Psychiatric API Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Psychiatric API Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Psychiatric API Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Psychiatric API Revenue, 2018-2029
9.3 By Country, Global Psychiatric API Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Psychiatric API Market Size, 2018-2029
9.4.2 By Company, U.S. Psychiatric API Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Psychiatric API Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Psychiatric API Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Psychiatric API Market Size, 2018-2029
9.5.2 By Company, Europe Psychiatric API Sales Volume Market Share, 2022
9.5.3 By Type, Europe Psychiatric API Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Psychiatric API Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Psychiatric API Market Size, 2018-2029
9.6.2 By Company, China Psychiatric API Sales Volume Market Share, 2022
9.6.3 By Type, China Psychiatric API Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Psychiatric API Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Psychiatric API Market Size, 2018-2029
9.7.2 By Company, Japan Psychiatric API Sales Volume Market Share, 2022
9.7.3 By Type, Japan Psychiatric API Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Psychiatric API Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Psychiatric API Market Size, 2018-2029
9.8.2 By Company, South Korea Psychiatric API Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Psychiatric API Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Psychiatric API Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Psychiatric API Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Psychiatric API Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Psychiatric API Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Psychiatric API Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Psychiatric API Market Size, 2018-2029
9.10.2 By Company, India Psychiatric API Sales Volume Market Share, 2022
9.10.3 By Type, India Psychiatric API Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Psychiatric API Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Psychiatric API Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Psychiatric API Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Psychiatric API Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Psychiatric API Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Pfizer
10.1.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.1.2 Pfizer Psychiatric API Models, Specifications and Application
10.1.3 Pfizer Psychiatric API Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Pfizer Company Profile and Main Business
10.1.5 Pfizer Recent Developments
10.2 Eli Lilly
10.2.1 Eli Lilly Company Information, Head Office, Market Area and Industry Position
10.2.2 Eli Lilly Psychiatric API Models, Specifications and Application
10.2.3 Eli Lilly Psychiatric API Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Eli Lilly Company Profile and Main Business
10.2.5 Eli Lilly Recent Developments
10.3 Salutas Pharma
10.3.1 Salutas Pharma Company Information, Head Office, Market Area and Industry Position
10.3.2 Salutas Pharma Psychiatric API Models, Specifications and Application
10.3.3 Salutas Pharma Psychiatric API Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Salutas Pharma Company Profile and Main Business
10.3.5 Salutas Pharma Recent Developments
10.4 Bora Pharmaceutical
10.4.1 Bora Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.4.2 Bora Pharmaceutical Psychiatric API Models, Specifications and Application
10.4.3 Bora Pharmaceutical Psychiatric API Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Bora Pharmaceutical Company Profile and Main Business
10.4.5 Bora Pharmaceutical Recent Developments
10.5 Dr.Reddy's Laboratories
10.5.1 Dr.Reddy's Laboratories Company Information, Head Office, Market Area and Industry Position
10.5.2 Dr.Reddy's Laboratories Psychiatric API Models, Specifications and Application
10.5.3 Dr.Reddy's Laboratories Psychiatric API Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Dr.Reddy's Laboratories Company Profile and Main Business
10.5.5 Dr.Reddy's Laboratories Recent Developments
10.6 Germany Pharmaceutical
10.6.1 Germany Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.6.2 Germany Pharmaceutical Psychiatric API Models, Specifications and Application
10.6.3 Germany Pharmaceutical Psychiatric API Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Germany Pharmaceutical Company Profile and Main Business
10.6.5 Germany Pharmaceutical Recent Developments
10.7 Hengrui Pharmaceuticals
10.7.1 Hengrui Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.7.2 Hengrui Pharmaceuticals Psychiatric API Models, Specifications and Application
10.7.3 Hengrui Pharmaceuticals Psychiatric API Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Hengrui Pharmaceuticals Company Profile and Main Business
10.7.5 Hengrui Pharmaceuticals Recent Developments
10.8 Herui Pharmaceutical
10.8.1 Herui Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.8.2 Herui Pharmaceutical Psychiatric API Models, Specifications and Application
10.8.3 Herui Pharmaceutical Psychiatric API Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Herui Pharmaceutical Company Profile and Main Business
10.8.5 Herui Pharmaceutical Recent Developments
10.9 Ren An Pharmaceutical
10.9.1 Ren An Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.9.2 Ren An Pharmaceutical Psychiatric API Models, Specifications and Application
10.9.3 Ren An Pharmaceutical Psychiatric API Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Ren An Pharmaceutical Company Profile and Main Business
10.9.5 Ren An Pharmaceutical Recent Developments
10.10 Yaopharma
10.10.1 Yaopharma Company Information, Head Office, Market Area and Industry Position
10.10.2 Yaopharma Psychiatric API Models, Specifications and Application
10.10.3 Yaopharma Psychiatric API Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Yaopharma Company Profile and Main Business
10.10.5 Yaopharma Recent Developments
10.11 Kanghong Pharmaceutical
10.11.1 Kanghong Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.11.2 Kanghong Pharmaceutical Psychiatric API Models, Specifications and Application
10.11.3 Kanghong Pharmaceutical Psychiatric API Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Kanghong Pharmaceutical Company Profile and Main Business
10.11.5 Kanghong Pharmaceutical Recent Developments
10.12 Brilliant Pharmaceutical
10.12.1 Brilliant Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.12.2 Brilliant Pharmaceutical Psychiatric API Models, Specifications and Application
10.12.3 Brilliant Pharmaceutical Psychiatric API Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Brilliant Pharmaceutical Company Profile and Main Business
10.12.5 Brilliant Pharmaceutical Recent Developments
10.13 Dongting Pharmaceutical
10.13.1 Dongting Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.13.2 Dongting Pharmaceutical Psychiatric API Models, Specifications and Application
10.13.3 Dongting Pharmaceutical Psychiatric API Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Dongting Pharmaceutical Company Profile and Main Business
10.13.5 Dongting Pharmaceutical Recent Developments
10.14 Sichuan Chuanda West China Pharmaceutical
10.14.1 Sichuan Chuanda West China Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.14.2 Sichuan Chuanda West China Pharmaceutical Psychiatric API Models, Specifications and Application
10.14.3 Sichuan Chuanda West China Pharmaceutical Psychiatric API Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Sichuan Chuanda West China Pharmaceutical Company Profile and Main Business
10.14.5 Sichuan Chuanda West China Pharmaceutical Recent Developments
10.15 Yangtze River Pharmaceutical
10.15.1 Yangtze River Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.15.2 Yangtze River Pharmaceutical Psychiatric API Models, Specifications and Application
10.15.3 Yangtze River Pharmaceutical Psychiatric API Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Yangtze River Pharmaceutical Company Profile and Main Business
10.15.5 Yangtze River Pharmaceutical Recent Developments
10.16 Huahai Pharmaceutical
10.16.1 Huahai Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.16.2 Huahai Pharmaceutical Psychiatric API Models, Specifications and Application
10.16.3 Huahai Pharmaceutical Psychiatric API Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Huahai Pharmaceutical Company Profile and Main Business
10.16.5 Huahai Pharmaceutical Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
Table 1. Psychiatric API Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Psychiatric API Market Restraints
Table 3. Psychiatric API Market Trends
Table 4. Psychiatric API Industry Policy
Table 5. Global Psychiatric API Revenue by Company, 2018-2023, US$ million
Table 6. Global Psychiatric API Revenue Market Share by Company, 2018-2023
Table 7. Global Psychiatric API Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Psychiatric API Sales Volume Market Share by Company, 2018-2023
Table 9. Global Psychiatric API Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Psychiatric API Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Psychiatric API Mergers & Acquisitions, Expansion Plans
Table 12. Global Psychiatric API Manufacturers Product Type
Table 13. China Psychiatric API Revenue by Company, 2018-2023, US$ million
Table 14. China Psychiatric API Revenue Market Share by Company, 2018-2023
Table 15. China Psychiatric API Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Psychiatric API Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Psychiatric API Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Psychiatric API Import & Export Trends
Table 19. Main Sources of China Psychiatric API Import
Table 20. Export Destination of China Psychiatric API
Table 21. Global Headquarters and Manufacturing Base of Psychiatric API Manufacturers
Table 22. Global Major Manufacturers, Psychiatric API Capacity Expansion and Future Plans
Table 23. Global Psychiatric API Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Psychiatric API Production by Region, 2018-2023, (K Units)
Table 25. Global Psychiatric API Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Psychiatric API Upstream (Raw Materials)
Table 27. Global Psychiatric API Typical Customers
Table 28. Psychiatric API Typical Distributors
Table 29. By Type, Global Psychiatric API Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Psychiatric API Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Psychiatric API Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Psychiatric API Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Psychiatric API Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Psychiatric API Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Psychiatric API Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Psychiatric API Revenue Market Share, 2018-2029
Table 37. By Country, Global Psychiatric API Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Psychiatric API Sales Volume Market Share, 2018-2029
Table 39. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 40. Pfizer Psychiatric API Models, Specifications and Application
Table 41. Pfizer Psychiatric API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Pfizer Company Profile and Main Business
Table 43. Pfizer Recent Developments
Table 44. Eli Lilly Company Information, Head Office, Market Area and Industry Position
Table 45. Eli Lilly Psychiatric API Models, Specifications and Application
Table 46. Eli Lilly Psychiatric API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Eli Lilly Company Profile and Main Business
Table 48. Eli Lilly Recent Developments
Table 49. Salutas Pharma Company Information, Head Office, Market Area and Industry Position
Table 50. Salutas Pharma Psychiatric API Models, Specifications and Application
Table 51. Salutas Pharma Psychiatric API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Salutas Pharma Company Profile and Main Business
Table 53. Salutas Pharma Recent Developments
Table 54. Bora Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 55. Bora Pharmaceutical Psychiatric API Models, Specifications and Application
Table 56. Bora Pharmaceutical Psychiatric API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Bora Pharmaceutical Company Profile and Main Business
Table 58. Bora Pharmaceutical Recent Developments
Table 59. Dr.Reddy's Laboratories Company Information, Head Office, Market Area and Industry Position
Table 60. Dr.Reddy's Laboratories Psychiatric API Models, Specifications and Application
Table 61. Dr.Reddy's Laboratories Psychiatric API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Dr.Reddy's Laboratories Company Profile and Main Business
Table 63. Dr.Reddy's Laboratories Recent Developments
Table 64. Germany Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 65. Germany Pharmaceutical Psychiatric API Models, Specifications and Application
Table 66. Germany Pharmaceutical Psychiatric API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Germany Pharmaceutical Company Profile and Main Business
Table 68. Germany Pharmaceutical Recent Developments
Table 69. Hengrui Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 70. Hengrui Pharmaceuticals Psychiatric API Models, Specifications and Application
Table 71. Hengrui Pharmaceuticals Psychiatric API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Hengrui Pharmaceuticals Company Profile and Main Business
Table 73. Hengrui Pharmaceuticals Recent Developments
Table 74. Herui Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 75. Herui Pharmaceutical Psychiatric API Models, Specifications and Application
Table 76. Herui Pharmaceutical Psychiatric API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Herui Pharmaceutical Company Profile and Main Business
Table 78. Herui Pharmaceutical Recent Developments
Table 79. Ren An Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 80. Ren An Pharmaceutical Psychiatric API Models, Specifications and Application
Table 81. Ren An Pharmaceutical Psychiatric API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Ren An Pharmaceutical Company Profile and Main Business
Table 83. Ren An Pharmaceutical Recent Developments
Table 84. Yaopharma Company Information, Head Office, Market Area and Industry Position
Table 85. Yaopharma Psychiatric API Models, Specifications and Application
Table 86. Yaopharma Psychiatric API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Yaopharma Company Profile and Main Business
Table 88. Yaopharma Recent Developments
Table 89. Kanghong Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 90. Kanghong Pharmaceutical Psychiatric API Models, Specifications and Application
Table 91. Kanghong Pharmaceutical Psychiatric API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Kanghong Pharmaceutical Company Profile and Main Business
Table 93. Kanghong Pharmaceutical Recent Developments
Table 94. Brilliant Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 95. Brilliant Pharmaceutical Psychiatric API Models, Specifications and Application
Table 96. Brilliant Pharmaceutical Psychiatric API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Brilliant Pharmaceutical Company Profile and Main Business
Table 98. Brilliant Pharmaceutical Recent Developments
Table 99. Dongting Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 100. Dongting Pharmaceutical Psychiatric API Models, Specifications and Application
Table 101. Dongting Pharmaceutical Psychiatric API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Dongting Pharmaceutical Company Profile and Main Business
Table 103. Dongting Pharmaceutical Recent Developments
Table 104. Sichuan Chuanda West China Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 105. Sichuan Chuanda West China Pharmaceutical Psychiatric API Models, Specifications and Application
Table 106. Sichuan Chuanda West China Pharmaceutical Psychiatric API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Sichuan Chuanda West China Pharmaceutical Company Profile and Main Business
Table 108. Sichuan Chuanda West China Pharmaceutical Recent Developments
Table 109. Yangtze River Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 110. Yangtze River Pharmaceutical Psychiatric API Models, Specifications and Application
Table 111. Yangtze River Pharmaceutical Psychiatric API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Yangtze River Pharmaceutical Company Profile and Main Business
Table 113. Yangtze River Pharmaceutical Recent Developments
Table 114. Huahai Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 115. Huahai Pharmaceutical Psychiatric API Models, Specifications and Application
Table 116. Huahai Pharmaceutical Psychiatric API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Huahai Pharmaceutical Company Profile and Main Business
Table 118. Huahai Pharmaceutical Recent Developments
List of Figure
Figure 1. Psychiatric API Picture
Figure 2. By Revenue, Global Psychiatric API Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Psychiatric API Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Psychiatric API Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Psychiatric API Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Psychiatric API Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Psychiatric API Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Psychiatric API Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Psychiatric API Share of Global Market, 2018-2029
Figure 10. Global Psychiatric API Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Psychiatric API Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Psychiatric API Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Psychiatric API Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Psychiatric API Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Psychiatric API Domestic VS Export, 2022
Figure 16. Global Psychiatric API Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Psychiatric API Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Psychiatric API Production Market Share & Forecast by Region, 2018-2029
Figure 19. Psychiatric API Industry Chain
Figure 20. Psychiatric API Procurement Model
Figure 21. Psychiatric API Sales Model
Figure 22. Psychiatric API Sales Channels, Direct Sales and Distribution
Figure 23. Venlafaxine
Figure 24. Duloxetine
Figure 25. Olanzapine
Figure 26. Paroxetine
Figure 27. Others
Figure 28. By Type, Global Psychiatric API Revenue, 2018-2029, US$ Million
Figure 29. By Type, Global Psychiatric API Revenue Market Share, 2018-2029
Figure 30. By Type, Global Psychiatric API Sales Volume, 2018-2029, (K Units)
Figure 31. By Type, Global Psychiatric API Sales Volume Market Share, 2018-2029
Figure 32. By Type, Global Psychiatric API Price, 2018-2029, (US$/Unit)
Figure 33. Major Depressive Disorder
Figure 34. Generalized Anxiety Disorder
Figure 35. Fibromyalgia
Figure 36. Schizophrenia
Figure 37. Others
Figure 38. By Application, Global Psychiatric API Revenue, 2018-2029, US$ Million
Figure 39. By Application, Global Psychiatric API Revenue Market Share, 2018-2029
Figure 40. By Application, Global Psychiatric API Sales Volume, 2018-2029, (K Units)
Figure 41. By Application, Global Psychiatric API Sales Volume Market Share, 2018-2029
Figure 42. By Application, Global Psychiatric API Price, 2018-2029, (US$/Unit)
Figure 43. By Region, Global Psychiatric API Revenue Market Share, 2018-2029
Figure 44. By Region, Global Psychiatric API Sales Volume Market Share, 2018-2029
Figure 45. North America Psychiatric API Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, North America Psychiatric API Revenue Market Share, 2022
Figure 47. Europe Psychiatric API Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. By Country, Europe Psychiatric API Revenue Market Share, 2022
Figure 49. Asia Pacific Psychiatric API Revenue & Forecasts, 2018-2029, US$ Million
Figure 50. By Country/Region, Asia Pacific Psychiatric API Revenue Market Share, 2022
Figure 51. South America Psychiatric API Revenue & Forecasts, 2018-2029, US$ Million
Figure 52. By Country, South America Psychiatric API Revenue Market Share, 2022
Figure 53. Middle East & Africa Psychiatric API Revenue & Forecasts, 2018-2029, US$ Million
Figure 54. U.S. Psychiatric API Sales Volume, 2018-2029, (K Units)
Figure 55. By Company, U.S. Psychiatric API Market Share, 2022
Figure 56. By Type, U.S. Psychiatric API Sales Volume Market Share, 2022 VS 2029
Figure 57. By Application, U.S. Psychiatric API Sales Volume Market Share, 2022 VS 2029
Figure 58. Europe Psychiatric API Sales Volume, 2018-2029, (K Units)
Figure 59. By Company, Europe Psychiatric API Market Share, 2022
Figure 60. By Type, Europe Psychiatric API Sales Volume Market Share, 2022 VS 2029
Figure 61. By Application, Europe Psychiatric API Sales Volume Market Share, 2022 VS 2029
Figure 62. China Psychiatric API Sales Volume, 2018-2029, (K Units)
Figure 63. By Company, China Psychiatric API Market Share, 2022
Figure 64. By Type, China Psychiatric API Sales Volume Market Share, 2022 VS 2029
Figure 65. By Application, China Psychiatric API Sales Volume Market Share, 2022 VS 2029
Figure 66. Japan Psychiatric API Sales Volume, 2018-2029, (K Units)
Figure 67. By Company, Japan Psychiatric API Market Share, 2022
Figure 68. By Type, Japan Psychiatric API Sales Volume Market Share, 2022 VS 2029
Figure 69. By Application, Japan Psychiatric API Sales Volume Market Share, 2022 VS 2029
Figure 70. South Korea Psychiatric API Sales Volume, 2018-2029, (K Units)
Figure 71. By Company, South Korea Psychiatric API Market Share, 2022
Figure 72. By Type, South Korea Psychiatric API Sales Volume Market Share, 2022 VS 2029
Figure 73. By Application, South Korea Psychiatric API Sales Volume Market Share, 2022 VS 2029
Figure 74. Southeast Asia Psychiatric API Sales Volume, 2018-2029, (K Units)
Figure 75. By Company, Southeast Asia Psychiatric API Market Share, 2022
Figure 76. By Type, Southeast Asia Psychiatric API Sales Volume Market Share, 2022 VS 2029
Figure 77. By Application, Southeast Asia Psychiatric API Sales Volume Market Share, 2022 VS 2029
Figure 78. India Psychiatric API Sales Volume, 2018-2029, (K Units)
Figure 79. By Company, India Psychiatric API Market Share, 2022
Figure 80. By Type, India Psychiatric API Sales Volume Market Share, 2022 VS 2029
Figure 81. By Application, India Psychiatric API Sales Volume Market Share, 2022 VS 2029
Figure 82. Middle East & Asia Psychiatric API Sales Volume, 2018-2029, (K Units)
Figure 83. By Company, Middle East & Asia Psychiatric API Market Share, 2022
Figure 84. By Type, Middle East & Asia Psychiatric API Sales Volume Market Share, 2022 VS 2029
Figure 85. By Application, Middle East & Asia Psychiatric API Sales Volume Market Share, 2022 VS 2029
Figure 86. Research Methodology
Figure 87. Breakdown of Primary Interviews
Figure 88. Bottom-up Approaches
Figure 89. Top-down Approaches
Research Methodology:
Global Psychiatric API Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|